4//SEC Filing
Coleman Mark 4
Accession 0000950170-25-079229
CIK 0001579428other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 7:00 PM ET
Size
7.5 KB
Accession
0000950170-25-079229
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Sale
Common Stock
2025-05-28$103.43/sh−3,750$387,863→ 46,637 total - Sale
Common Stock
2025-05-27$105.47/sh−3,750$395,513→ 50,387 total
Holdings
- 403,856(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Represents the sale of underlying shares of previously exercised stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $104.75 and $106.50.
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $102.71 and $104.38.
- [F5]Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001658379
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 7:00 PM ET
- Size
- 7.5 KB